INNS for kinase inhibitors - January 2011
There are two new kinase inhibitor INNs in the latest WHO list of proposed INNs. (There are other kinase inhibitors in this document, but there are not new INNs/USANs - but if anyone knows anything about pacritinib I'd be glad to hear).
Alisertib a.k.a. MLN-8237 - Millenium's Aurora kinase inhibitor, InChI key: APEDHRWNPCHTHU-UHFFFAOYSA-N InChI: InChI=1S/C27H19ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35) Phase 2
Cenisertib a.k.a. AS-703569 and R-763 - Merck Serono's Aurora kinase inhibitor, InChI key: KSOVGRCOLZZTPF-QMKUDKLTSA-N InChI=1S/C24H30FN7O/c1-14-11-17(5-6-19(14)32-9-7-31(2)8-10-32)28-24-27-13-18(25)23(30-24)29-21-16-4-3-15(12-16)20(21)22(26)33/h3-6,11,13,15-16,20-21H,7-10,12H2,1-2H3,(H2,26,33)(H2,27,28,29,30)/t15-,16+,20+,21-/m1/s1 Phase 1